Clinical Trial Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Clinical Trial Imaging Market Growth & Vendors and it is segmented by Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, and Imaging Software), Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, and Other Modalities), End User (Pharmaceutical Companies, Medical Device Manufacturers, and Academic and Government Research Institutes), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Clinical Trial Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Clinical Trial Imaging Market Size

Clinical Trial Imaging Market Summary
Study Period 2021 - 2030
Market Size (2025) USD 1.32 Billion
Market Size (2030) USD 1.71 Billion
CAGR (2025 - 2030) 5.38 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Clinical Trial Imaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Clinical Trial Imaging Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Clinical Trial Imaging Market Analysis

The Clinical Trial Imaging Market size is estimated at USD 1.32 billion in 2025, and is expected to reach USD 1.71 billion by 2030, at a CAGR of 5.38% during the forecast period (2025-2030).

Clinical trials are used in the development and testing of vaccines and other therapeutics; they have been essential in containing the COVID-19 pandemic. For instance, using low-field magnetic resonance imaging, the University of Erlangen-Nürnberg Medical School started a clinical study in August 2021 to assess the prevalence of pulmonary skeletal changes in children and adolescents with verified past SARS-CoV-2 infection (LF-MRI).

Increasing research and development by the key market players during the pandemic is expected to increase market growth during the forecast period. For instance, in August 2021, the government of Canada announced an agreement with leading COVID-19 vaccine developer Moderna, Inc. to build an mRNA vaccine facility in Canada. The goals of the recently unveiled biomanufacturing and life science strategy were in line with Moderna's aspirations to build an mRNA vaccine manufacturing facility in Canada. This is anticipated to drive the clinical trial imaging market growth in Canada, driving the overall growth of the market.

The clinical trial imaging market is expected to grow also due to the rise in the number of contract research organizations, an increase in R&D spending, and growth in pharmaceutical and biotechnological companies. In recent years, various pharmaceutical companies and government organizations have increased their spending on research and development (R&D), which is anticipated to drive the market growth over the forecast period. For example, in FY 2021 Novartis AG, one of the leading participants in the studied market, invested USD 14,886 million, up from USD 14,197 million in the previous year, according to annual reports. Such large investments will provide an impetus to market growth.

Additionally, the market is expected to grow as a result of increased investment in research and development in the biopharmaceutical industry. For instance, the annual research and development expenditure of the biopharmaceutical industry has been 7.3 times greater than that of the aerospace and defense industries, 6.5 times greater than that of the chemicals industry, and 1.5 times greater than that of the software and computer services industry, as per our analysis. Further, as per the IFPMA, in 2022, over 202 billion is estimated to have been spent around the world in biopharmaceutical research and development. The enormous investments in the market are considered a result of the rising acceptance of biopharmaceuticals over the years.

Similarly, increasing contract research organizations are expected to increase the market growth. For instance, in September 2021, Insights Research Organization and Solutions (IROS) - a Contract Research Organization (CRO) in the UAE was launched, specializing in healthcare research and solutions to cover all therapeutic areas.

However, high implementation barriers and costs of imaging systems are expected to hinder market growth.

Clinical Trial Imaging Industry Overview

The Clinical Trial Imaging Market is moderately competitive and consists of several major players. The key participants of the market studied include Koninklijke Philips N.V, Ixico PLC, Icon PLC, WIRB-Copernicus Group, and Navitas Clinical Research, Inc among others. These major players are undertaking growth strategies such as new product launches, mergers, and acquisitions to retain shares and diversify their product portfolios.

Clinical Trial Imaging Market Leaders

  1. Koninklijke Philips N.V

  2. Icon PLC

  3. WIRB-Copernicus Group

  4. Ixico PLC

  5. Navitas Clinical Research, Inc

  6. *Disclaimer: Major Players sorted in no particular order
Clinical Trial Imaging Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Clinical Trial Imaging Market News

  • In May 2022, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2022 conference, Bruker launched innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio.
  • In March 2022, Fujifilm India unveiled a new range of CT, MRI, and ultrasound machines in India. A wide range of equipment, including computed tomography (CT), magnetic resonance imaging (MR)I, X-ray, artificial intelligence, endoscopy, and ultrasound systems through the Scenaria View, Supria series, The Echelon Smart, and Arietta series, are included in the most recent portfolio.

Clinical Trial Imaging Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in R&D Spending by the Pharmaceutical and Biotechnological Companies
    • 4.2.2 Increasing Number of Contract Research Organization & Investment by Them
  • 4.3 Market Restraints
    • 4.3.1 High Implementation Barriers and Costs of Imaging Systems
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product and Service
    • 5.1.1 Trial Design Consulting Services
    • 5.1.2 Read Analysis Services
    • 5.1.3 Operational Imaging Services
    • 5.1.4 Imaging Software
  • 5.2 By Modality
    • 5.2.1 Magnetic Resonance Imaging
    • 5.2.2 Computed Tomography
    • 5.2.3 Ultrasound
    • 5.2.4 Positron Emission Tomography
    • 5.2.5 X-Ray
    • 5.2.6 Echocardiography
    • 5.2.7 Other Modalities
  • 5.3 By End-User
    • 5.3.1 Pharmaceutical & Biotechnology Companies
    • 5.3.2 Medical Device Manufacturers
    • 5.3.3 Academic and Government Research Institutes
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Clario
    • 6.1.2 Icon PLC
    • 6.1.3 Ixico PLC
    • 6.1.4 Koninklijke Philips N.V
    • 6.1.5 Medpace
    • 6.1.6 Navitas Clinical Research, Inc
    • 6.1.7 Parexel International Corporation
    • 6.1.8 ProScan Imaging
    • 6.1.9 Radiant Sage LLC
    • 6.1.10 Resonance Health
    • 6.1.11 WIRB-Copernicus Group
    • 6.1.12 Worldcare Clinical LLC
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Clinical Trial Imaging Industry Segmentation

Clinical trial imaging is an important part of the research and development process in the pharmaceutical and biotechnology industries. The usage of medical imaging is now recognized in clinical trials to make trials more effective and accurate. The Clinical Trial Imaging Market is segmented by Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, and Imaging Software), Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, and Other Modalities), End User (Pharmaceutical Companies, Medical Device Manufacturers, and Academic and Government Research Institutes), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product and Service Trial Design Consulting Services
Read Analysis Services
Operational Imaging Services
Imaging Software
By Modality Magnetic Resonance Imaging
Computed Tomography
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities
By End-User Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers
Academic and Government Research Institutes
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Clinical Trial Imaging Market Research FAQs

How big is the Clinical Trial Imaging Market?

The Clinical Trial Imaging Market size is expected to reach USD 1.32 billion in 2025 and grow at a CAGR of 5.38% to reach USD 1.71 billion by 2030.

What is the current Clinical Trial Imaging Market size?

In 2025, the Clinical Trial Imaging Market size is expected to reach USD 1.32 billion.

Who are the key players in Clinical Trial Imaging Market?

Koninklijke Philips N.V, Icon PLC, WIRB-Copernicus Group, Ixico PLC and Navitas Clinical Research, Inc are the major companies operating in the Clinical Trial Imaging Market.

Which is the fastest growing region in Clinical Trial Imaging Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Clinical Trial Imaging Market?

In 2025, the North America accounts for the largest market share in Clinical Trial Imaging Market.

What years does this Clinical Trial Imaging Market cover, and what was the market size in 2024?

In 2024, the Clinical Trial Imaging Market size was estimated at USD 1.25 billion. The report covers the Clinical Trial Imaging Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Clinical Trial Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Clinical Trial Imaging Industry Report

Statistics for the 2025 Clinical Trial Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Clinical Trial Imaging analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.